ARID2 and liver cancer: Chronic hepatitis showed a strong impact on the mutational landscape in liver cancer and the genetic diversity among biliary differentiated liver cancers, where recurrent mutations in TERT promoter, chromatin regulators (BAP1, PBRM1 and ARID2), a synapse organization gene (PCLO), IDH genes and KRAS were identified.